Back to Search Start Over

Efficacy and Safety Evaluation of Systemic Extremely Low Frequency Magnetic Fields Used in the Healing of Diabetic Foot Ulcers–Phase II Data.

Authors :
Cañedo-Dorantes, Luis
Soenksen, Luis R.
García-Sánchez, Clara
Trejo-Núñez, Daphny
Pérez-Chávez, Fernando
Guerrero, Arturo
Cardona-Vicario, Melisa
García-Lara, Carlos
Collí-Magaña, Dianelly
Serrano-Luna, Gregorio
Angeles Chimal, José S.
Cabrera, Guillermo
Source :
Archives of Medical Research. Aug2015, Vol. 46 Issue 6, p470-478. 9p.
Publication Year :
2015

Abstract

Background and Aims Cellular and animal models investigating extremely low frequency magnetic fields (ELF-MF) have reported promotion of leukocyte-endothelial interactions, angiogenesis, myofibroblast and keratinocyte proliferation, improvement of peripheral neuropathy and diabetic wound healing. In humans, it has also been reported that systemic exposure to ELF-MF stimulates peripheral blood mononuclear cells, promoting angiogenesis and healing of chronic leg ulcers. The aim of the study was to investigate the effect of exposing different blood volumes to specific ELF-MFs (120 Hz sinusoidal waves of 0.4–0.9 mT RMS) to induce healing of diabetic foot ulcers (DFUs). Methods Twenty six diabetic patients with non-responsive DFUs were divided into two exposure groups to receive treatment and record healing time. The forearm group, exposed to ELF-MF 2 h/day, twice weekly (3.6 l of blood/session); and the thorax group, exposed 25 min/day, 2 times/week (162.5 l of blood/session). Treatment period was 100 days or upon complete healing. Ulcer recurrences and adverse effects were investigated during short-term (<1 year) and long-term (3.4–7.8 years) follow-up. Results Mean healing time was 61.48 ± 33.08 days in the forearm group and 62.56 ± 29.33 days for the thorax group. No adverse effects or ulcer recurrences in the original ulcer site were reported during treatment, the short-term follow-up period or the long-term follow-up period in both groups. Conclusions Healing time was independent of the amount of blood exposed to ELF-MF used in this trial. ELF-MFs are effective and safe and could be applied to non-healing DFUs in conjunction with other preventive interventions to reduce DFUs complications. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01884409
Volume :
46
Issue :
6
Database :
Academic Search Index
Journal :
Archives of Medical Research
Publication Type :
Academic Journal
Accession number :
109357298
Full Text :
https://doi.org/10.1016/j.arcmed.2015.07.002